Comparativein vitroactivities of ceftaroline and ceftriaxone against bacterial pathogens associated with respiratory tract infections: results from the AWARE surveillance study | Zendy

Douglas J. Biedenbach | Zendy; Joseph P. Iaconis | Zendy; D.F. Sahm | Zendy

Open Access

Comparativein vitroactivities of ceftaroline and ceftriaxone against bacterial pathogens associated with respiratory tract infections: results from the AWARE surveillance study

Author(s) -

Douglas J. Biedenbach,

Joseph P. Iaconis,

D.F. Sahm

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw315

Subject(s) - ceftriaxone , moraxella catarrhalis , microbiology and biotechnology , streptococcus pneumoniae , haemophilus influenzae , medicine , respiratory tract infections , broth microdilution , cephalosporin , staphylococcus aureus , antibiotics , minimum inhibitory concentration , biology , bacteria , respiratory system , genetics

Ceftaroline fosamil is indicated for the treatment of community-acquired bacterial pneumonia and ceftriaxone has an indication for lower respiratory tract infections. This study was conducted to compare the relative in vitro activities of these two agents against bacterial species associated with community-associated respiratory tract infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research